Acquisition History / CVC Capital Partners and Groupe Bruxelles Lambert consortium / Recordati S.p.A.

CVC Capital Partners and Groupe Bruxelles Lambert consortium Acquires Recordati S.p.A.

Announced May 2026 — $12.52B

CVC Capital Partners and Groupe Bruxelles Lambert consortiumPharmaceuticals2026

What happened

Recordati is an Italian pharmaceutical group. CVC Capital Partners, which already controlled a vehicle holding about 46.8%, and Belgian investor Groupe Bruxelles Lambert, together with Abu Dhabi Investment Authority and CPP Investments, launched a €10.7B cash offer to take the company private.

Acquirer
CVC Capital Partners and Groupe Bruxelles Lambert consortium
Target
Recordati S.p.A.
Announced
May 2026
Price
$12.52B
Industry
Pharmaceuticals
Buyer type
Private equity
Backing investors
CVC Capital Partners, Groupe Bruxelles Lambert, Abu Dhabi Investment Authority, CPP Investments
Status
Announced, not yet closed

By the numbers

CVC Capital Partners and Groupe Bruxelles Lambert consortium's acquisition history
1st of 1 tracked deals
Disclosed prices
1 of 1 CVC Capital Partners and Groupe Bruxelles Lambert consortium deals
CVC Capital Partners and Groupe Bruxelles Lambert consortium's average disclosed price
$12.52B
CVC Capital Partners and Groupe Bruxelles Lambert consortium's largest disclosed deal
Recordati S.p.A. ($12.52B)
Tracked acquisitions in 2026
397 across all acquirers
CVC Capital Partners and Groupe Bruxelles Lambert consortium in Pharmaceuticals
1 acquisition

Frequently Asked Questions About This Acquisition

When did CVC Capital Partners and Groupe Bruxelles Lambert consortium acquire Recordati S.p.A.?

CVC Capital Partners and Groupe Bruxelles Lambert consortium acquired Recordati S.p.A. on May 2026. This was CVC Capital Partners and Groupe Bruxelles Lambert consortium's 1st publicly tracked acquisition out of 1 we have on record.

How much did CVC Capital Partners and Groupe Bruxelles Lambert consortium pay for Recordati S.p.A.?

CVC Capital Partners and Groupe Bruxelles Lambert consortium paid $12.52B for Recordati S.p.A..

What does Recordati S.p.A. do?

Recordati is an Italian pharmaceutical group. CVC Capital Partners, which already controlled a vehicle holding about 46.8%, and Belgian investor Groupe Bruxelles Lambert, together with Abu Dhabi Investment Authority and CPP Investments, launched a €10.7B cash offer to take the company private.

What other Pharmaceuticals companies has CVC Capital Partners and Groupe Bruxelles Lambert consortium acquired?

Recordati S.p.A. is CVC Capital Partners and Groupe Bruxelles Lambert consortium's only publicly tracked acquisition in Pharmaceuticals so far.

Read the full article →

More Pharmaceuticals acquisitions